You are here

Sanofi

With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans

With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans

BioSpace

Flag link:

New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics

New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics

Xtalks

multiple sclerosis

Flag link:

Upcoming events – Pfizer's abrocitinib and Myovant's relugolix

Upcoming events – Pfizer's abrocitinib and Myovant's relugolix

EP Vantage

uterine fibroids

Flag link:

Two Big Drug Flops Show How Health-Care Economics Have Changed

Two Big Drug Flops Show How Health-Care Economics Have Changed

Bloomberg

Flag link:

B-MS, Sanofi Claim Hawaii is Violating Their Free Speech in Plavix Suit

B-MS, Sanofi Claim Hawaii is Violating Their Free Speech in Plavix Suit

RAPS.org

freedom of speech

Bristol-Myers Squibb

Flag link:

Stop and plan it out: Sanofi CEO Paul Hudson offers up advice for digitally ambitious pharmas

Stop and plan it out: Sanofi CEO Paul Hudson offers up advice for digitally ambitious pharmas

Fierce Pharma

Flag link:

A big finish confirms 2019 as a takeover year to remember

A big finish confirms 2019 as a takeover year to remember

EP Vantage

Bristol-Myers Squibb

Flag link:

Regeneron to lay off field staffers as it restructures Sanofi partnership

Regeneron to lay off field staffers as it restructures Sanofi partnership

Fierce Pharma

Flag link:

Sanofi beat out 3 suitors and one last-minute bid in its pricey $2.5B Synthorx buyout

Sanofi beat out 3 suitors and one last-minute bid in its pricey $2.5B Synthorx buyout

Fierce Pharma

Flag link:

Are Changes in Store for Verily’s Diabetes Joint Venture?

Are Changes in Store for Verily’s Diabetes Joint Venture?

Medical Devices and Diagnostics Industry

Flag link:

Novartis top of pile in European pharma in 2020, say Jefferies analysts

Novartis top of pile in European pharma in 2020, say Jefferies analysts

Pharmaforum

Flag link:

After big M&A year, will pharma move away from massive deals in 2020?

After big M&A year, will pharma move away from massive deals in 2020?

Fierce Pharma

Bristol-Myers Squibb

Flag link:

Sanofi Says Its $2.5 Billion Biotech Takeover Is Just the Beginning

Sanofi Says Its $2.5 Billion Biotech Takeover Is Just the Beginning

Motley Fool

immuno-oncology

Flag link:

Sanofi CEO turns to 'cobots' and AI to zap manufacturing costs

Sanofi CEO turns to 'cobots' and AI to zap manufacturing costs

Fierce Pharma

drug manufacturing

artificial intelligence

Flag link:

Sanofi, Regeneron to Amend Agreement for Kevzara & Praulent

Sanofi, Regeneron to Amend Agreement for Kevzara & Praulent

Yahoo/Zacks.com

Flag link:

Leo's Dupixent rival hits all endpoints in pivotal program

Leo's Dupixent rival hits all endpoints in pivotal program

Fierce Biotech

atopic dermatitis

Flag link:

Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It Sounds Like a Good Deal for Both

Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It Sounds Like a Good Deal for Both

Motley Fool

immuno-oncology

Flag link:

Sanofi CEO Hudson backs away from struggling diabetes, cardiovascular areas in strategy unveiling

Sanofi CEO Hudson backs away from struggling diabetes, cardiovascular areas in strategy unveiling

Fierce Pharma

cardiovascular death

Flag link:

ASH: Sanofi eyes FDA filing as orphan blood drug hits late-phase goal

ASH: Sanofi eyes FDA filing as orphan blood drug hits late-phase goal

Fierce Biotech

clinical trials

cold agglutinin disease

Flag link:

Sanofi says Dupixent could be a $10 billion drug, aims to sell Cialis and Tamiflu over the counter

Sanofi says Dupixent could be a $10 billion drug, aims to sell Cialis and Tamiflu over the counter

Stat

Flag link:

Pages